Back to results
US 2016/0250164 A1Published application
Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alfa-adrenergic and/or beta-adrenergic receptors of the sympathetic nervous system, related to improved clot strength
AssigneeRigshospitalet
InventorsPär Johansson, Niels H. Secher, Louise Bochsen
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel use and methods of treatment using sympathicomimetic agonists with pro-hemostatic activity.
Claims21
-89. (canceled)
A method for treatment or prophylaxis of bleeding in a subject with subnormal clot strength and stability, the method comprising administration of an effective amount of an adrenergic receptor agonist to said subject.
A method for treatment or prophylaxis of bleeding in a subject suffering from thrombocytopenia, the method comprising administration of an effective amount of an adrenergic receptor agonist to said subject.
Dependencies are inferred from the claim text.